AntiVirii 60 caps
antiVIRII for Influenza USA ONLY
Disclaimer: This is not a claim for treating COVID-19. The virus has yet to be mapped, however Panaxea Anti-Virii has a number of studies on the influenza virus. Secondly Anti-Virii has multiple anti-inflammatory properties as well as being pulmonary protective. Prof Weber developed this formulation in 2003 for the SARS epidemic.*
Developed from research by Prof Daniel Weber and being used since 2003.
Anti-viral, Anti-tumoral support
Ingredients
Serving Size: 3 capsules.
Andrographis Paniculata (contains: standardized Andrographolide 95%) 150mg
Taraxacum Officinalis (contains: standardized Taraxasterol 20%) 600mg
Lonerica Japonica (contains: standardized Chlorogenic acid 25%) *
Dosage
Suggested Use: 2-3 caps, 2-3 times daily. 3 times daily for one month. Cautions: pregnancy and lactation.